Development of Newer Calcium Channel Antagonists: Therapeutic Potential of Efonidipine in Preventing Electrical Remodelling during Atrial Fibrillation

Author： Ohashi Narutaka  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.1, 2009-01, pp. : 21-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of the Cardioselective, Sarcolemmal KATP Channel Blocker HMR 1098 on Atrial Electrical Remodeling During Pacing-Induced Atrial Fibrillation in Dogs

By Vereckei András   Gögelein Heinz   Wirth Klaus   Zipes Douglas  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 23-30

Springer Publishing Company

Access to resources Recommend Favorite

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

Calcium Channel Antagonists in the Treatment of Hypertension

By Weber M.A.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 6, 2002-01 ,pp. : 415-431

Adis International

Access to resources Recommend Favorite

Effects of Ca 2+ channel antagonists on sinus node: Prolongation of late phase 4 depolarization by efonidipine

By Masumiya H.   Tanaka H.   Shigenobu K.  

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 15-21

Elsevier

Access to resources Recommend Favorite

The Development of Cytokine Receptor Antagonists as Potential Therapeutic Agents for the Myeloproliferative Disorders

By  

Current Pharmaceutical Design, Vol. 8, Iss. 5, 2002-03 ,pp. : 357-368

Bentham Science Publishers

Access to resources Recommend Favorite